Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCIT versus methylphenidate in preschool children with ADHD and disruptive behavior after insufficient response to parent management training
NL-OMON36319Recruiting
- Sponsor
- Accare
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), oppositional defiant disorder (ODD), conduct disorder (CD) and 1 more (2 arms), sponsored by Accare. Primary endpoint: Primary caretaker Eyberg Child Behavior Inventory. Started Apr 2011; status: recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)oppositional defiant disorder (ODD)conduct disorder (CD)Disruptive behavior disorders (DBD)
Beyond the preview
Go deeper on NL-OMON36319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36319.